Theranostic cobalt-55/58m for neurotensin receptor-mediated radiotherapy in vivo: A pilot study with dosimetry-Reference-Cited by-同舟云学术

Theranostic cobalt-55/58m for neurotensin receptor-mediated radiotherapy in vivo: A pilot study with dosimetry

Published:2023-03 Issue: Volume:118-119 Page:108329
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Lin Wilson,Aluicio-Sarduy Eduardo,Houson Hailey A.,Barnhart Todd E.,Tekin Volkan,Jeffery Justin J.,Weichmann Ashley M.,Barrett Kendall E.,Lapi Suzanne E.,Engle Jonathan W.

Funder

National Institutes of Health

National Cancer Institute

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Reference38 articles.

1. Correlation of dose with toxicity and tumour response to 90Y- and 177Lu-PRRT provides the basis for optimization through individualized treatment planning;Cremonesi;Eur J Nucl Med Mol Imaging,2018

2. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution;Uusijärvi;Med Phys,2006

3. Production, purification, and applications of a potential theranostic pair: Cobalt-55 and Cobalt-58m;Barrett;Diagnostics,2021

4. The beginning and development of the theranostic approach in nuclear medicine, as exemplified by the radionuclide pair 86Y and 90Y;Rösch;Pharmaceuticals,2017

5. Evaluation of cobalt-labeled octreotide analogs for molecular imaging and auger electron-based radionuclide therapy;Thisgaard;J Nucl Med,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PET Imaging of Differentiated Thyroid Cancer with TSHR-Targeted [⁸⁹Zr]Zr-TR1402;Molecular Pharmaceutics;2024-07-08

2. Synthesis of⁶⁴Cu-,⁵⁵Co-, and⁶⁸Ga-Labeled Radiopharmaceuticals Targeting Neurotensin Receptor-1 for Theranostics: Adjusting In Vivo Distribution Using Multiamine Macrocycles;Journal of Nuclear Medicine;2024-06-13

3. The future of the radiopharmaceutical sciences;Nuclear Medicine and Biology;2024-05

4. Radiolabeling Diaminosarcophagine with Cyclotron-Produced Cobalt-55 and [⁵⁵Co]Co-NT-Sarcage as a Proof of Concept in a Murine Xenograft Model;Bioconjugate Chemistry;2024-02-27

5. Preclinical evaluation of [58mCo]Co-DOTA-PSMA-617 for Auger electron therapy of prostate cancer;Scientific Reports;2023-11-01